Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Propionylshikonin is a natural naphthoquinone derivative found in the roots of the Lithospermum erythrorhizon plant, also known as red-rooted gromwell. It has been studied for its potential medicinal properties, including anti-inflammatory, anti-cancer, and anti-microbial effects. Its unique chemical structure and bioactivity make it a promising candidate for various therapeutic applications.

162283-70-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 162283-70-7 Structure
  • Basic information

    1. Product Name: propionylshikonin
    2. Synonyms: propionylshikonin;5,8-Dihydroxy-2-[(1R)-4-methyl-1-(1-oxopropoxy)-3-penten-1-yl]-1,4-naphthalenedione
    3. CAS NO:162283-70-7
    4. Molecular Formula: C19H20O6
    5. Molecular Weight: 344.3585
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 162283-70-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 560.2°Cat760mmHg
    3. Flash Point: 200.9°C
    4. Appearance: /
    5. Density: 1.297
    6. Vapor Pressure: 3.72E-13mmHg at 25°C
    7. Refractive Index: 1.593
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: propionylshikonin(CAS DataBase Reference)
    11. NIST Chemistry Reference: propionylshikonin(162283-70-7)
    12. EPA Substance Registry System: propionylshikonin(162283-70-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 162283-70-7(Hazardous Substances Data)

162283-70-7 Usage

Uses

Used in Cancer Treatment:
Propionylshikonin is used as an anti-cancer agent for its ability to inhibit the growth of various cancer cell lines. It modulates multiple signaling pathways involved in cancer progression, making it a potential therapeutic agent for the treatment of different types of cancer.
Used in Inflammatory Disease Treatment:
Propionylshikonin is used as an anti-inflammatory agent for its capacity to reduce the production of inflammatory mediators in immune cells. This property makes it a potential candidate for the treatment of inflammatory diseases, where controlling inflammation is crucial for disease management.
Used in Antimicrobial Therapy:
Propionylshikonin is used as an antibacterial and antifungal agent due to its demonstrated activities against several pathogens. Its broad-spectrum antimicrobial properties suggest its potential use in treating infectious illnesses caused by bacteria and fungi.

Check Digit Verification of cas no

The CAS Registry Mumber 162283-70-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,2,8 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 162283-70:
(8*1)+(7*6)+(6*2)+(5*2)+(4*8)+(3*3)+(2*7)+(1*0)=127
127 % 10 = 7
So 162283-70-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H20O6/c1-4-16(23)25-15(8-5-10(2)3)11-9-14(22)17-12(20)6-7-13(21)18(17)19(11)24/h5-7,9,15,20-21H,4,8H2,1-3H3/t15-/m1/s1

162283-70-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name [(1R)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] propanoate

1.2 Other means of identification

Product number -
Other names 1,4-Naphthalenedione,5,8-dihydroxy-2-((1R)-4-methyl-1-(1-oxopropoxy)-3-pentenyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:162283-70-7 SDS

162283-70-7Downstream Products

162283-70-7Relevant articles and documents

Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorhizon

An, Sojin,Park, Yong-Dae,Paik, Young-Ki,Jeong, Tae-Sook,Lee, Woo Song

, p. 1112 - 1116 (2007)

Three naphthoquinones were isolated by bioassay-guided fractionation from the CHCl3 extracts of roots of Lithospermum erythrorhizon. They were identified as acetylshikonin (1), isobutyrylshikonin (2), and β-hydroxyisovalerylshikonin (3) on the basis of their spectroscopic analyses. The compounds 1-3 were tested for their inhibitory activities against human ACAT-1 (hACAT-1) or human ACAT-2 (hACAT-2). Compound 2 preferentially inhibited hACAT-2 (IC50 = 57.5 μM) than hACAT-1 (32% at 120 μM), whereas compounds 1 and 3 showed weak inhibitory activities in both hACAT-1 and -2. To develop more potent hACAT inhibitor, shikonin derivatives (5-11) were synthesized by semi-synthesis of shikonin (4), which was prepared by hydrolysis of 1-3. Among them, compounds 5 and 7 exhibited the strong inhibitory activities against hACAT-1 and -2. Furthermore, we demonstrated that compound 7 behaved as a potent ACAT inhibitor in not only in vitro assay system but also cell-based assay system.

Design and synthesis of fluoroacylshikonin as an anticancer agent

Kong, Wen-Yao,Chen, Xiao-Feng,Shi, Jing,Baloch, Shahla Karim,Qi, Jin-Liang,Zhu, Hai-Liang,Wang, Xiao-Ming,Yang, Yong-Hua

, p. 757 - 762 (2013/11/06)

A series of shikonin derivatives, selectively acylated by various fluorinated carboxylic acids at the side chain of shikonin, were synthesized and their anticancer activity evaluated, in which eight compounds are reported for the first time. Among all the compounds tested, compound S7 showed the most potent anticancer activity against B16-F10 (malignant melanoma cells), MG63 (human osteosarcoma cells), and A549 (lung cancer cells) with IC50 0.39 ± 0.01, 0.72 ± 0.04 and 0.58 ± 0.02 μmol/L. Docking simulation of compound S7 was carried out to position S7 into a tubulin active site to determine the probable binding conformation. All the results suggested that compound S7 may be a potential anticancer agent. Chirality 25:757-762, 2013. 2013 Wiley Periodicals, Inc. Copyright

Acylshikonin analogues: Synthesis and inhibition of DNA topoisomerase-I

Ahn,Baik,Kweon,Lim,Hwang

, p. 1044 - 1047 (2007/10/02)

Compounds bearing an acyl group of a various size at 1'-OH of shikonin were synthesized as acyl analogues of shikonin, which was isolated from the root of Lithospermum erythrorhizon, and evaluated for inhibitory effect on topoisomerase-I activity. A selec

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 162283-70-7